Key result
Despite more than 3 decades of experience with thrombolytic agents for acute pulmonary embolism, their role in treatment remains uncertain and controversial.
Design
Editorial
Authors
Loading...
Despite decades of experience, the role of thrombolytic therapy in treating acute pulmonary embolism remains uncertain and controversial.
Despite decades of experience, the role of thrombolytic therapy in treating acute pulmonary embolism remains uncertain and controversial.
James E. Dalen (2002) conducted a review in Acute pulmonary embolism (PE). Thrombolytic therapy was evaluated. Despite more than 3 decades of experience with thrombolytic agents for acute pulmonary embolism, their role in treatment remains uncertain and controversial.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: